Advertisement
U.S. markets closed
Advertisement

Shengfeng Development Limited (SFWL)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
15.15+0.12 (+0.80%)
At close: 04:00PM EST
14.84 -0.31 (-2.05%)
After hours: 05:35PM EST
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Commodity Channel Index

Commodity Channel Index

Previous Close15.03
Open15.11
Bid14.83 x 800
Ask15.94 x 800
Day's Range14.79 - 15.90
52 Week Range2.94 - 17.60
Volume240,825
Avg. Volume213,174
Market Cap1.248B
Beta (5Y Monthly)N/A
PE Ratio (TTM)108.21
EPS (TTM)0.14
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued
-42% Est. Return

Subscribe to Yahoo Finance Plus to view Fair Value for SFWL

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Shengfeng Development Limited
    Analyst Report: Eli Lilly and CompanyEli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Jardiance, Trulicity, Humalog, and Humulin for diabetes; and Taltz and Olumiant for immunology.
    Rating
    Fair Value
    Economic Moat
    last monthMorningstar
View more